- Supernus Pharmaceuticals (NASDAQ:SUPN): Q2 EPS of $0.08 may not be comparable to consensus of -$0.28.
- Revenue of $29.68M beats by $9.83M.
- Press Release
Supernus Pharmaceuticals EPS of $0.08
Recommended For You
More Trending News
About SUPN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SUPN | - | - |
Supernus Pharmaceuticals, Inc. |